Merrill Upgrades Cymer to 'Near-Term Buy'
Analyst Brett Hodess says fourth-quarter results beat his estimates as the tool manufacturer shifted to more expensive products
Merrill Lynch upgraded Cymer (CYMI ) to near-term buy from neutral.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.